Literature DB >> 17143326

Proinsulin: a unique autoantigen triggering autoimmune diabetes.

Sylvaine You1, Lucienne Chatenoud.   

Abstract

In healthy individuals the immune system does not react aggressively toward host cells, a phenomenon defined as self tolerance. If self tolerance is broken autoimmune disease can develop, during which autoreactive lymphocytes are directed to a variety of autoantigenic epitopes. However, researchers have yet to determine whether immune responses to multiple autoantigens develop independently of each other or are the result of the response "spreading" from one autoantigen to another. In a study of NOD mice in this issue of the JCI, Krishnamurthy et al. show that the autoreactive T cell response to the autoantigen proinsulin lies upstream of that to islet-specific glucose-6-phosphatase catalytic subunit-related protein, suggesting that the pathogenic autoimmune response to proinsulin subsequently spreads to other antigens (see the related article beginning on page 3258). These data support the current view that this pancreatic beta cell hormone is the first autoantigen targeted by the immune response in autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143326      PMCID: PMC1679718          DOI: 10.1172/JCI30760

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Epitope spreading in immune-mediated diseases: implications for immunotherapy.

Authors:  Carol L Vanderlugt; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.

Authors:  Balasubramanian Krishnamurthy; Nadine L Dudek; Mark D McKenzie; Anthony W Purcell; Andrew G Brooks; Shane Gellert; Peter G Colman; Leonard C Harrison; Andrew M Lew; Helen E Thomas; Thomas W H Kay
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

3.  GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.

Authors:  H Reijonen; T L Daniels; A Lernmark; G T Nepom
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

4.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

5.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

Authors:  R Tisch; X D Yang; S M Singer; R S Liblau; L Fugger; H O McDevitt
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

6.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.

Authors:  P V Lehmann; T Forsthuber; A Miller; E E Sercarz
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

7.  Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice.

Authors:  D R Wegmann; M Norbury-Glaser; D Daniel
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

8.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

9.  Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.

Authors:  A al-Sabbagh; A Miller; L M Santos; H L Weiner
Journal:  Eur J Immunol       Date:  1994-09       Impact factor: 5.532

10.  Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

Authors:  Scott M Lieberman; Anne M Evans; Bingye Han; Toshiyuki Takaki; Yuliya Vinnitskaya; Jennifer A Caldwell; David V Serreze; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Pere Santamaria; Teresa P DiLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  8 in total

1.  Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Parameters influencing antigen-specific immunotherapy for type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.

Authors:  V B Gibson; T Nikolic; V Q Pearce; J Demengeot; B O Roep; M Peakman
Journal:  Clin Exp Immunol       Date:  2015-09-17       Impact factor: 4.330

Review 4.  Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Authors:  Sofie Robert; Hannelie Korf; Conny Gysemans; Chantal Mathieu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

5.  Beta Cell Dedifferentiation Induced by IRE1α Deletion Prevents Type 1 Diabetes.

Authors:  Hugo Lee; Yong-Syu Lee; Quincy Harenda; Stefan Pietrzak; Hülya Zeynep Oktay; Sierra Schreiber; Yian Liao; Shreyash Sonthalia; Ashley E Ciecko; Yi-Guang Chen; Sunduz Keles; Rupa Sridharan; Feyza Engin
Journal:  Cell Metab       Date:  2020-03-26       Impact factor: 27.287

6.  CHOPPI: a web tool for the analysis of immunogenicity risk from host cell proteins in CHO-based protein production.

Authors:  Chris Bailey-Kellogg; Andres H Gutiérrez; Leonard Moise; Frances Terry; William D Martin; Anne S De Groot
Journal:  Biotechnol Bioeng       Date:  2014-07-14       Impact factor: 4.530

7.  The Serological and Biochemical Markers of Adrenal Cortex and Endocrine Pancreas Dysfunction in Patients with Hashimoto's Thyroiditis: A Hospital-based Pilot Study.

Authors:  Jaya Prakash Sahoo; Jayakumar Selviambigapathy; Sadishkumar Kamalanathan; V S Negi; M G Sridhar; Sitanshu Sekhar Kar; Muthupillai Vivekanandan
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug

Review 8.  Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.

Authors:  Charles J Kroger; Matthew Clark; Qi Ke; Roland M Tisch
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.